NCT00592995
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Massachusetts General Hospital Charlestown, Massachusetts, United States
Clinical trial condition
Huntington Disease
Explore clinical trials studying Huntington Disease. Study availability and eligibility vary by location and protocol.
141 public trials
32 recruiting studies
Huntington Disease trial results
NCT00277355
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Colorado Neurological Institute Englewood, Colorado, United States
- University of Florida Gainesville, Florida, United States
- University of South Florida Tampa, Florida, United States
Completed
Citalopram to Enhance Cognition in HD
NCT00271596
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Basal Ganglia Diseases, +20 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- The University of Iowa Iowa City, Iowa, United States
- University of Rochester Rochester, New York, United States
Completed
Atomoxetine and Huntington's Disease
NCT00368849
- Conditions
- Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Basal Ganglia Diseases, +19 more
- Locations
-
- The University of Iowa Iowa City, Iowa, United States
Completed
Memory Disorders Registry
NCT00654563
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +24 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
Completed
Riluzole in Huntington's Disease
NCT00277602
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
Not specified
NCT00988624
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +16 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00831506
- Conditions
- Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +15 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Completed
A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan
NCT00788047
- Conditions
- Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +15 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
NCT00075140
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- The University of Iowa College of Nursing Iowa City, Iowa, United States